🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Phase 3 study is intended to assess clinical lot-to-lot consistency by...
Status
Withdrawn
Location
Dawson Clinical Research
Start Date
2021-11-22
Trial ID
NCT05040789
Treatments Being Tested
In order to find the formulation leading to a maximal increase of the immun...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-10-05
Trial ID
NCT00540228
Treatments Being Tested
The purpose of this study is to assess the safety and immunogenicity of dif...
Status
Completed
Location
GSK Investigational Site
Start Date
2023-08-03
Trial ID
NCT05975840
Treatments Being Tested
This is a trial designed to assess the safety, reactogenicity and immunogen...
Status
Completed
Location
Emory Children's Center - Pediatric Infectious Diseases
Start Date
2018-08-21
Trial ID
NCT03589807
The main goals of this study are to assess the immune response and safety o...
Status
Active Not Recruiting
Location
Royal Inland Hospital
Start Date
2021-05-20
Trial ID
NCT04894435
The primary objectives of the study were: * To describe the neutralizing a...
Status
Completed
Location
Investigational Site Number 8400004
Start Date
2020-09-03
Trial ID
NCT04537208
The study is a prospective single site exploratory study to examine the imp...
Status
Completed
Location
The Hope Clinic of Emory University
Start Date
2018-10-11
Trial ID
NCT03701061
Treatments Being Tested
This Phase II randomized, double-blinded, controlled study in up to 1000 ma...
Status
Completed
Location
University of Maryland School of Medicine - Center for Vaccine Development - Baltimore
Start Date
2013-09
Trial ID
NCT01942265
Treatments Being Tested
The purpose of this placebo controlled study is to evaluate the safety and ...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-09-25
Trial ID
NCT01949090
Treatments Being Tested
This Phase 2/3 study is a multi-portion design to confirm that the chosen f...
Status
Active Not Recruiting
Location
Achieve Clinical Research, LLC dba Accel Research Sites
Start Date
2020-11-19
Trial ID
NCT04636697
Treatments Being Tested